Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer

ÇAĞLAR TUNCALI M., Bozkurt F. M., KAPULU AKÇA C. D., Vargol S. E., BAYRAKTAR M., UĞUR Ö., ...More

NUCLEAR MEDICINE COMMUNICATIONS, vol.33, no.3, pp.268-274, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 3
  • Publication Date: 2012
  • Doi Number: 10.1097/mnm.0b013e32834ec5d6
  • Journal Name: NUCLEAR MEDICINE COMMUNICATIONS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.268-274
  • Keywords: iodine-131, radioiodine ablation, thyroid cancer, LOW-DOSE RADIOIODINE, WHOLE-BODY SCAN, SERUM THYROGLOBULIN, RADIOACTIVE IODINE, FOLLOW-UP, THERAPY, CARCINOMA, PAPILLARY, ULTRASONOGRAPHY, MANAGEMENT
  • Hacettepe University Affiliated: Yes

Abstract

Introduction The initial treatment of differentiated thyroid cancer is thyroidectomy, followed by remnant ablation with iodine-131 (I-131) in some patients. However, controversy exists concerning the appropriate radioiodine dose. The aim of the study is to compare the success rate of low and high activities of I-131 for postoperative remnant ablation.